Advanced search
Publication Cover
Journal of Drug Targeting Volume 19, 2011 - Issue 2
Submit an article Journal homepage
294
Views
49
CrossRef citations to date
0
Altmetric
Original Article

SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood–brain barriers

Hend M. ShubarInstitute of Microbiology and Hygiene, Campus Benjamin Franklin, Charité-University Medicine Berlin, Berlin, Germany
,
Sabrina LachenmaierInstitute of Microbiology and Hygiene, Campus Benjamin Franklin, Charité-University Medicine Berlin, Berlin, Germany
,
Markus M. HeimesaatInstitute of Microbiology and Hygiene, Campus Benjamin Franklin, Charité-University Medicine Berlin, Berlin, Germany
,
Uwe LohmanInstitute of Microbiology and Hygiene, Campus Benjamin Franklin, Charité-University Medicine Berlin, Berlin, Germany
,
Rachmat MauludinDepartment of Pharmaceutical Technology, Biotechnology and Quality Management, Free University of Berlin, Berlin, Germany
,
Rainer H. MuellerDepartment of Pharmaceutical Technology, Biotechnology and Quality Management, Free University of Berlin, Berlin, Germany
,
Rudolf FitznerInstitute of Clinical Chemistry and Pathobiochemistry, Campus Benjamin Franklin, Charité-University Medicine Berlin, Germany
,
Klaus BornerInstitute of Clinical Chemistry and Pathobiochemistry, Campus Benjamin Franklin, Charité-University Medicine Berlin, Germany
&
Oliver LiesenfeldCorrespondence[email protected]
 show all
Pages 114-124 | Received 20 Dec 2009, Accepted 26 Feb 2010, Published online: 01 Apr 2010

Citations (49)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Aref Teimouri, Sanaz Jafarpour Azami, Hossein Keshavarz, Fariba Esmaeili, Rasoul Alimi, Sara Ayazian Mavi & Saeedeh Shojaee. (2018) Anti-Toxoplasma activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain. International Journal of Nanomedicine 13, pages 1341-1351.
Read now
Federica Leone & Roberta Cavalli. (2015) Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations. Expert Opinion on Drug Delivery 12:10, pages 1607-1625.
Read now
Kalpana Nagpal, Shailendra Kumar Singh & Dina Nath Mishra. (2013) Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB. Expert Opinion on Drug Delivery 10:7, pages 927-955.
Read now
Andrea Orthmann, Iduna Fichtner & Reiner Zeisig. (2011) Improving the transport of chemotherapeutic drugs across the blood–brain barrier. Expert Review of Clinical Pharmacology 4:4, pages 477-490.
Read now

Articles from other publishers (45)

Grzegorz Król, Kamila Fortunka, Michał Majchrzak, Ewelina Piktel, Paulina Paprocka, Angelika Mańkowska, Agata Lesiak, Maciej Karasiński, Agnieszka Strzelecka, Bonita Durnaś & Robert Bucki. (2023) Metallic Nanoparticles and Core-Shell Nanosystems in the Treatment, Diagnosis, and Prevention of Parasitic Diseases. Pathogens 12:6, pages 838.
Crossref
Bwalya A. Witika, Yahya E. Choonara & Patrick H. Demana. (2023) A SWOT analysis of nano co-crystals in drug delivery: present outlook and future perspectives. RSC Advances 13:11, pages 7339-7351.
Crossref
Yongjiu Lv, Wei Wu, Clairissa D. Corpstein, Tonglei Li & Yi Lu. (2022) Biological and intracellular fates of drug nanocrystals through different delivery routes: Recent development enabled by bioimaging and PK modeling. Advanced Drug Delivery Reviews 188, pages 114466.
Crossref
Shubham Mule, Pooja Khairnar & Rahul Shukla. (2022) Recent Advances in Nanocrystals Heralding Greater Potential in Brain Delivery. Particle & Particle Systems Characterization 39:9.
Crossref
Meenakshi Bhatia, Sunil Kumar, Archana Kapoor & Sunidhi Lohan. (2022) A Review on the Drug Delivery Strategies for Parasitic Infections: Scope and Assertion. Drug Delivery Letters 12:2, pages 109-121.
Crossref
S S Sanjay, Shashiprabha, K Shridhara & K Nagarajan. (2022) Synthesis, structural elucidation and reaction optimization studies of a novel prodrug of Atovaquone. Journal of Chemical Sciences 134:1.
Crossref
Layane Alencar Costa Nascimento, Romulo Oliveira Sousa, Marcos Paulo Oliveira Almeida, Yusmaris Cariaco, Angelica Oliveira Gomes, Natália Carnevalli Miranda, Flávia Batista Ferreira França, Mariele de Fátima Alves Venâncio, Carlos Antonio Trindade Silva, Wânia Rezende Lima, Bellisa Freitas Barbosa, Jane Lima Santos & Neide Maria Silva. (2022) The ethanolic extract of the fungus Trichoderma stromaticum decreases the Toxoplasma gondii replication in vitro and ameliorates the experimental toxoplasmosis in vivo. Current Research in Microbial Sciences 3, pages 100173.
Crossref
Shweta Sinha & Rakesh Sehgal. 2022. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance 395 424 .
Amanpreet Kaur, Prashantkumar Khodabhai Parmar, Sanika Jadhav & Arvind Kumar Bansal. 2022. Nanoparticle Therapeutics. Nanoparticle Therapeutics 413 454 .
Nesrein M. Hashem & Antonio Gonzalez-Bulnes. (2021) Nanotechnology and Reproductive Management of Farm Animals: Challenges and Advances. Animals 11:7, pages 1932.
Crossref
Sanaz Jafarpour Azami, Hanieh Mohammad Rahimi, Hamed Mirjalali & Mohammad Reza Zali. (2021) Unravelling Toxoplasma treatment: conventional drugs toward nanomedicine. World Journal of Microbiology and Biotechnology 37:3.
Crossref
Vivek P. Patel, Dhara V. Patel & Jayvadan K. Patel. 2021. Emerging Technologies for Nanoparticle Manufacturing. Emerging Technologies for Nanoparticle Manufacturing 39 66 .
Hany M. Elsheikha, Christina M. Marra & Xing-Quan Zhu. (2020) Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis. Clinical Microbiology Reviews 34:1.
Crossref
Orestis Antonoglou, Kleoniki Giannousi, Stefanos Mourdikoudis & Catherine Dendrinou-Samara. (2020) Magnetic nanoemulsions as candidates for Alzheimer’s disease dual imaging theranostics. Nanotechnology 31:46, pages 465702.
Crossref
Kourosh Cheraghipour, Leila Masoori, Fatemeh Ezzatkhah, Iraj Salimikia, Sana Amiri, Ali Safar Makenali, Farshad Taherpour & Hossein Mahmoudvand. (2020) Effect of chitosan on Toxoplasma gondii infection: A systematic review. Parasite Epidemiology and Control 11, pages e00189.
Crossref
Carsten G.K. Lüder, Utz Reichard & Uwe Groß. 2020. Toxoplasma gondii. Toxoplasma gondii 321 365 .
Brenna Louise Cavalcanti Gondim, Jonatas da Silva Catarino, Marlos Aureliano Dias de Sousa, Mariana de Oliveira Silva, Marcela Rezende Lemes, Tamires Marielem de Carvalho-Costa, Tatiana Rita de Lima Nascimento, Juliana Reis Machado, Virmondes Rodrigues, Carlo José Freire Oliveira, Lúcio Roberto Cançado Castellano & Marcos Vinicius da Silva. (2019) Nanoparticle-Mediated Drug Delivery: Blood-Brain Barrier as the Main Obstacle to Treating Infectious Diseases in CNS. Current Pharmaceutical Design 25:37, pages 3983-3996.
Crossref
Mamunur Rashid, Mohd Yaseen Malik, Sandeep K. Singh, Swati Chaturvedi, Jiaur R Gayen & Muhammad Wahajuddin. (2019) Bioavailability Enhancement of Poorly Soluble Drugs: The Holy Grail in Pharma Industry. Current Pharmaceutical Design 25:9, pages 987-1020.
Crossref
Mamdouh M. Hegazy, Manar S. Elmehankar, Manar S. Azab, Nora L. El-Tantawy & Azza Abdel-Aziz. (2019) Sex dichotomy in the course of experimental latent toxoplasmosis. Experimental Parasitology 202, pages 15-21.
Crossref
Brice Martin Couillaud, Philippe Espeau, Nathalie Mignet & Yohann Corvis. (2018) State of the Art of Pharmaceutical Solid Forms: from Crystal Property Issues to Nanocrystals Formulation. ChemMedChem 14:1, pages 8-23.
Crossref
Ildiko Rita Dunay, Kiran Gajurel, Reshika Dhakal, Oliver Liesenfeld & Jose G. Montoya. (2018) Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice. Clinical Microbiology Reviews 31:4.
Crossref
Maria Gigliobianco, Cristina Casadidio, Roberta Censi & Piera Di Martino. (2018) Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability. Pharmaceutics 10:3, pages 134.
Crossref
Sanaz Jafarpour Azami, Amir Amani, Hossein Keshavarz, Roqya Najafi-Taher, Mehdi Mohebali, Mohammad Ali Faramarzi, Mahmood Mahmoudi & Saeedeh Shojaee. (2018) Nanoemulsion of atovaquone as a promising approach for treatment of acute and chronic toxoplasmosis. European Journal of Pharmaceutical Sciences 117, pages 138-146.
Crossref
German A. Islan, Marcela Durán, Maximiliano L. Cacicedo, Gerson Nakazato, Renata K.T. Kobayashi, Diego S.T. Martinez, Guillermo R. Castro & Nelson Durán. (2017) Nanopharmaceuticals as a solution to neglected diseases: Is it possible?. Acta Tropica 170, pages 16-42.
Crossref
João Paulo Assolini, Virginia Márcia Concato, Manoela Daiele Gonçalves, Amanda Cristina Machado Carloto, Ivete Conchon-Costa, Wander Rogério Pavanelli, Francine Nesello Melanda & Idessania Nazareth Costa. (2017) Nanomedicine advances in toxoplasmosis: diagnostic, treatment, and vaccine applications. Parasitology Research 116:6, pages 1603-1615.
Crossref
Mahbobeh Montazeri, Mehdi Sharif, Shahabeddin Sarvi, Saeed Mehrzadi, Ehsan Ahmadpour & Ahmad Daryani. (2017) A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006–2016). Frontiers in Microbiology 8.
Crossref
Gang SHEN, Ling CHENG, Li-Qiang WANG, Li-Hong ZHANG, Bao-De SHEN, Wei-Bo LIAO, Juan-Juan LI, Juan ZHENG, Rong XU & Hai-Long YUAN. (2016) Formulation of dried lignans nanosuspension with high redispersibility to enhance stability, dissolution, and oral bioavailability. Chinese Journal of Natural Medicines 14:10, pages 757-768.
Crossref
Annika Tuomela, Jukka Saarinen, Clare J. Strachan, Jouni Hirvonen & Leena Peltonen. (2016) Production, applications and in vivo fate of drug nanocrystals. Journal of Drug Delivery Science and Technology 34, pages 21-31.
Crossref
Laxman Kate, Vinod Gokarna, Vivek Borhade, Priyanka Prabhu, Vinita Deshpande, Sulabha Pathak, Shobhona Sharma & Vandana Patravale. (2016) Bioavailability enhancement of atovaquone using hot melt extrusion technology. European Journal of Pharmaceutical Sciences 86, pages 103-114.
Crossref
Ranjita Shegokar. 2016. Handbook of Nanoparticles. Handbook of Nanoparticles 385 406 .
Jaroslav Flegr. (2015) Neurological and Neuropsychiatric Consequences of Chronic Toxoplasma Infection. Current Clinical Microbiology Reports 2:4, pages 163-172.
Crossref
Ranjita Shegokar. 2015. Handbook of Nanoparticles. Handbook of Nanoparticles 1 17 .
William Wei Lim Chin, Johannes Parmentier, Michael Widzinski, En Hui Tan & Rajeev Gokhale. (2014) A Brief Literature and Patent Review of Nanosuspensions to a Final Drug Product. Journal of Pharmaceutical Sciences 103:10, pages 2980-2999.
Crossref
M.R. Gaafar, R.F. Mady, R.G. Diab & Th.I. Shalaby. (2014) Chitosan and silver nanoparticles: Promising anti-toxoplasma agents. Experimental Parasitology 143, pages 30-38.
Crossref
Anju Malkani, Abhijit A. Date & Darshana Hegde. (2014) Celecoxib nanosuspension: single-step fabrication using a modified nanoprecipitation method and in vivo evaluation. Drug Delivery and Translational Research 4:4, pages 365-376.
Crossref
Vivek K. Pawar, Yuvraj Singh, Jaya Gopal Meher, Siddharth Gupta & Manish K. Chourasia. (2014) Engineered nanocrystal technology: In-vivo fate, targeting and applications in drug delivery. Journal of Controlled Release 183, pages 51-66.
Crossref
Vivek Borhade, Sulabha Pathak, Shobhona Sharma & Vandana Patravale. (2014) Formulation and characterization of atovaquone nanosuspension for improved oral delivery in the treatment of malaria. Nanomedicine 9:5, pages 649-666.
Crossref
Kenia Pissinate, Érica dos Santos Martins-Duarte, Scheila Rezende Schaffazick, Catiúscia Padilha de Oliveira, Rossiane Cláudia Vommaro, Sílvia Stanisçuaski Guterres, Adriana Raffin Pohlmann & Wanderley de Souza. (2013) Pyrimethamine-loaded lipid-core nanocapsules to improve drug efficacy for the treatment of toxoplasmosis. Parasitology Research 113:2, pages 555-564.
Crossref
Carsten G.K. Lüder, Utz Reichard & Uwe Gross. 2014. Toxoplasma Gondii. Toxoplasma Gondii 217 255 .
S. Scerra, H. Coignard-Biehler, F. Lanternier, F. Suarez, C. Charlier-Woerther, M.-E. Bougnoux, J. Gilquin, M. Lecuit, O. Hermine & O. Lortholary. (2013) Disseminated toxoplasmosis in non-allografted patients with hematologic malignancies: report of two cases and literature review. European Journal of Clinical Microbiology & Infectious Diseases 32:10, pages 1259-1268.
Crossref
Shegokar Ranjita. (2013) Nanosuspensions: a new approach for organ and cellular targeting in infectious diseases. Journal of Pharmaceutical Investigation 43:1, pages 1-26.
Crossref
Lei Gao, Guiyang Liu, Jianli Ma, Xiaoqing Wang, Liang Zhou, Xiang Li & Fang Wang. (2012) Application of Drug Nanocrystal Technologies on Oral Drug Delivery of Poorly Soluble Drugs. Pharmaceutical Research 30:2, pages 307-324.
Crossref
Ronize Andréia Ferreira, Alaide Braga de Oliveira, Simone Andrade Gualberto, José M. Miguel Del Corral, Ricardo Toshio Fujiwara, Pedro Henrique Gazzinelli Guimarães & Ricardo Wagner de Almeida Vitor. (2012) New naphthoquinones and an alkaloid with in vitro activity against Toxoplasma gondii RH and EGS strains. Experimental Parasitology 132:4, pages 450-457.
Crossref
Bo Sun & Yoon Yeo. (2012) Nanocrystals for the parenteral delivery of poorly water-soluble drugs. Current Opinion in Solid State and Materials Science 16:6, pages 295-301.
Crossref
Lei Gao, Guiyang Liu, Jianli Ma, Xiaoqing Wang, Liang Zhou & Xiang Li. (2012) Drug nanocrystals: In vivo performances. Journal of Controlled Release 160:3, pages 418-430.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.